Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 2 Interventional

Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL

ClinicalTrials.gov ID: NCT03097107

Public ClinicalTrials.gov record NCT03097107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL

Study identification

NCT ID
NCT03097107
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 2
Lead sponsor
Zydus Therapeutics Inc.
Industry
Enrollment
124 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • Saroglitazar Magnesium 1 mg Drug
  • Saroglitazar Magnesium 2 mg Drug
  • Saroglitazar Magnesium 4 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 5, 2017
Primary completion
Nov 30, 2023
Completion
Dec 31, 2023
Last update posted
Feb 7, 2023

2017 – 2024

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801
Encompass Clinical Research Encinitas California 92023
Integrated Research Center San Diego California 92117
Ventura Clinical Trials Ventura California 93003
Colorado Springs Health Partners Colorado Springs Colorado 80906
Meridien Research - Bradenton Bradenton Florida 34201
Meridien Research - Lakeland Lakeland Florida 33805
Oviedo Medical Research, LLC Oviedo Florida 32765
Meridien Research - Tampa Tampa Florida 33634
River Birch Research Alliance LLC Blue Ridge Georgia 30513
Drug Studies America Marietta Georgia 30060
Herman Clinical Research, LLC Suwanee Georgia 30024
Cedar-Crosse Research Center Chicago Illinois 60607
Heartland Research Associates, LLC Newton Kansas 67114
Heartland Research Associates, LLC Wichita Kansas 67205
University of Maryland Medical Center Baltimore Maryland 21201
Centennial Medical Group Elkridge Maryland 21075
MD Medical Research Oxon Hill Maryland 20745
Mercury Street Medical Butte Montana 59701
Einstein Clinical Research Charlotte North Carolina 28277
Triad Clinical Trials LLC Greensboro North Carolina 27410
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Metabolic and Atherosclerosis Research Center Cincinnati Ohio 45227
Sterling Research Group, Ltd. Cincinnati Ohio 45246
Wells Institute for Health Awareness Kettering Ohio 45429
Ohio Clinical Research - Lyndhurst Lyndhurst Ohio 44124
Awasty Research Network, LLC Marion Ohio 43302
Ohio Clinical Research, LLC - Willoughby Hills Willoughby Hills Ohio 44094
Columbia Research Group, Inc. Portland Oregon 97239
PMG Research of Bristol, LLC Bristol Tennessee 37620
Jackson Clinic Jackson Tennessee 38301
Pioneer Research Solutions Inc. Houston Texas 77099
National Clinical Research - Richmond, Inc Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03097107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2023 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03097107 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →